top of page

Our Mission

Although mosaic embryo transfer is currently offered as an option for women who undergo IVF, several concerns remain, especially regarding clinical outcomes of mosaic embryos. We aim to increase the currently limited data surrounding mosaic embryo transfer by collecting prospective and retrospective data on mosaic embryo transfer and its prenatal and postnatal outcome. We also hope to promote the formulation of an evidence-based priority scheme for mosaic embryos in the clinic. Finally, we strive to provide guidance and networking opportunities to PGT centres.

Our Plan

Our Team

Dr. Francesca Spinella
Dr. Svetlana Madjunkova
thumbnail_Picture1 (3).png

Dr. Manuel Viotti

Founder

Dr. Francesca Spinella

Founder

Dr. Svetlana Madjunkova

Founder

Andria G. Besser

Founder

Awards & Recognition

First Prize

American Society of Reproductive Medicine (ASRM) Congress 2023 New Orleans, LA

Prize Paper Award

Society of Reproductive Biologists & Technologists (SRBT), 2022

New York Times, April 2021

Article highlighting our study on 1,000 mosaic embryo transfers:

https://www.nytimes.com/2021/04/06/well/family/in-vitro-fertilization-mosaic-embryo.html

Prize Paper Session

American Society of Reproductive Medicine (ASRM) Virtual Congress 2020

Contact Us

For any questions or inquiries

  • Facebook
  • Twitter
  • LinkedIn
  • Instagram

Thanks for submitting!

bottom of page